BioMarin Pharmaceutical attained the first FDA approval for a gene therapy indicated to treat severe hemophilia A.
Read the full post on Becker's Hospital Review - Healthcare News
1st gene therapy for severe hemophilia A approved
BioMarin Pharmaceutical attained the first FDA approval for a gene therapy indicated to treat severe hemophilia A.
Read the full post on Becker's Hospital Review - Healthcare News